Reelin glycoprotein treatment rescue experiment

PRIMARY OUTCOME

restoration of cerebral blood flow and protection against Aβ toxicity

EXPECTED OUTCOMES

1. The intervention targeting CD2AP shifts restoration of cerebral blood flow and protection against Aβ toxicity in the predicted direction relative to the matched control arm. 2. Secondary disease-relevant readouts in Alzheimer's disease remain directionally concordant with the primary endpoint rather than showing isolated single-assay effects. 3. The effect persists after adjustment for baseline covariates, batch effects, or repeated-measures structure used in the study design.

SUCCESS CRITERIA

- Prespecified primary endpoint (restoration of cerebral blood flow and protection against Aβ toxicity) improves versus control with p < 0.05 or an equivalent corrected threshold used by the study. - The effect size is biologically meaningful and reproduced across technical/biological replicates or the validation subset. - Safety, data quality, and missingness remain within protocol-defined bounds so the result is interpretable rather than driven by attrition or assay failure.

PROTOCOL

1. Establish mice cohorts for Alzheimer's disease and predefine inclusion, exclusion, and quality-control criteria before intervention. 2. Apply the experimental manipulation described for CD2AP, alongside matched control or comparator arms, and document dose, exposure window, and sample timing in a locked protocol log. 3. Measure restoration of cerebral blood flow and protection against Aβ toxicity together with orthogonal secondary readouts such as molecular, imaging, behavioral, or safety endpoints that are appropriate to the title and study design. 4. Use blinded outcome assessment where feasible, prespecified statistical analysis, and replicate the core readout across biological replicates or an independent validation subset. 5. Interpret results against the baseline study rationale: Treatment of CD2AP mutant mice with reelin glycoprotein to test whether this intervention could mitigate the effects of CD2AP loss of function via ApoER2 signaling. The experiment examined whether reelin treatment could restore cerebrovascular function and pro

LINKED HYPOTHESES

HTML iframe

<iframe src="http://scidex.ai/artifact/exp-cc23af71-9fe9-47f6-aebd-28da541e7eb7?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>

Markdown link

[Reelin glycoprotein treatment rescue experiment](http://scidex.ai/artifact/exp-cc23af71-9fe9-47f6-aebd-28da541e7eb7)

Direct URL

http://scidex.ai/artifact/exp-cc23af71-9fe9-47f6-aebd-28da541e7eb7

Preview